Literature DB >> 27591900

A mechanism for propagated SOD1 misfolding from frustration analysis of a G85R mutant protein assembly.

Eamonn F Healy1.   

Abstract

Application of landscape theory and the dehydron hypothesis to a crystal structure of a G85R mutant superoxide dismutase (SOD1) tetrameric complex allows for the description of a prion-like hypothesis that serves to explain propagated SOD1 misfolding. We have developed two conformational-change scenarios, one local to the ESL at the complex interface, and a second displacement at the ESL of the otherdimeric subunit. When taken together these provide for a prion-like mechanism that can serve to explain the observed conversion of wtSOD1 to a misfolded form by the G85R mutant.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Dehydrons; Electrostatic loop; Frustration contacts; G85R SOD1 mutant; Superoxide dismutase

Mesh:

Substances:

Year:  2016        PMID: 27591900      PMCID: PMC5030186          DOI: 10.1016/j.bbrc.2016.08.172

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Protein topology determines binding mechanism.

Authors:  Yaakov Levy; Peter G Wolynes; José N Onuchic
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

2.  Insufficiently dehydrated hydrogen bonds as determinants of protein interactions.

Authors:  Ariel Fernández; Harold A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

Review 3.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

4.  SOD1 exhibits allosteric frustration to facilitate metal binding affinity.

Authors:  Atanu Das; Steven S Plotkin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

Review 5.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.

Authors:  Christian Haass; Dennis J Selkoe
Journal:  Nat Rev Mol Cell Biol       Date:  2007-02       Impact factor: 94.444

6.  Tyrosine kinase inhibition: Ligand binding and conformational change in c-Kit and c-Abl.

Authors:  Eamonn F Healy; Skylar Johnson; Charles R Hauser; Peter J King
Journal:  FEBS Lett       Date:  2009-08-04       Impact factor: 4.124

7.  Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme.

Authors:  Mercedes Prudencio; Armando Durazo; Julian P Whitelegge; David R Borchelt
Journal:  J Neurochem       Date:  2008-12-11       Impact factor: 5.372

8.  Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS.

Authors:  Jennifer Stine Elam; Alexander B Taylor; Richard Strange; Svetlana Antonyuk; Peter A Doucette; Jorge A Rodriguez; S Samar Hasnain; Lawrence J Hayward; Joan Selverstone Valentine; Todd O Yeates; P John Hart
Journal:  Nat Struct Biol       Date:  2003-06

9.  Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS.

Authors:  Daryl A Bosco; Gerardo Morfini; N Murat Karabacak; Yuyu Song; Francois Gros-Louis; Piera Pasinelli; Holly Goolsby; Benjamin A Fontaine; Nathan Lemay; Diane McKenna-Yasek; Matthew P Frosch; Jeffrey N Agar; Jean-Pierre Julien; Scott T Brady; Robert H Brown
Journal:  Nat Neurosci       Date:  2010-10-17       Impact factor: 24.884

10.  Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases.

Authors:  Jacob I Ayers; Guilian Xu; Olga Pletnikova; Juan C Troncoso; P John Hart; David R Borchelt
Journal:  Acta Neuropathol Commun       Date:  2014-05-14       Impact factor: 7.801

View more
  1 in total

1.  A prion-like mechanism for the propagated misfolding of SOD1 from in silico modeling of solvated near-native conformers.

Authors:  Eamonn F Healy
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.